Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Dora Games(Athena Group (United States)), David S. Adams(Worcester Polytechnic Institute), Ree Alessandrini(Exemplar Genetics (United States)), Robin Barbour(Athena Group (United States)), Patricia Borthelette, Catherine Blackwell(University of Massachusetts Amherst), Tony Carr(Athena Group (United States)), James A. Clemens(Eli Lilly (United States)), Thomas Donaldson(Exemplar Genetics (United States)), Frances P. Gillespie(Exemplar Genetics (United States)), Terry Guido(Athena Group (United States)), S. Hagopian(Boston Children's Hospital), Kelly Johnson‐Wood(Athena Group (United States)), Karen Khan(Athena Group (United States)), Mike Lee(Athena Group (United States)), Paul J. Leibowitz(Exemplar Genetics (United States)), Ivan Lieberburg(Athena Group (United States)), Sheila P. Little(Eli Lilly (United States)), Eliezer Masliah(University of California, San Diego), Lisa McConlogue(Athena Group (United States)), Martin Montoya‐Zavala(Exemplar Genetics (United States)), Lennart Mucke(Scripps Research Institute), Lisa Paganini(Athena Group (United States)), Elizabeth Penniman(Exemplar Genetics (United States)), Mike Power(Athena Group (United States)), Dale Schenk(Athena Group (United States)), Peter Seubert(Athena Group (United States)), Ben Snyder(Exemplar Genetics (United States)), Ferdie Soriano(Athena Group (United States)), Hua Tan(Athena Group (United States)), James Vitale(Millennium Engineering and Integration (United States)), Sam Wadsworth(Exemplar Genetics (United States)), Ben Wolozin(National Institute of Mental Health), Jun Zhao(Athena Group (United States))
Cited by 2,502
Abstract
Related Papers
No related papers found
Powered by citation graph analysis